Category: CovidienSyndicate content

Varicose vein treatment: VenaSeal wins FDA approval

February 20, 2015 by Brian Johnson

Federal regulators say they have approved the VenaSeal closure system to treat varicose veins

Covidien study: VenaSeal effective in treating leg veins

Covidien's VenaSeal closure system to treat varicose veins has been approved by the U.S. Food and Drug Administration, according to an agency press release.

Medtronic's managed services biz books $1B in sales

February 18, 2015 by Brian Johnson

Medtronic CEO Omar Ishrak tells analysts the company's managed services business for cath labs is expanding into new markets, with booked sales topping the $1 billion mark through its fiscal 3rd quarter.

Medtronic's expanding services biz tops $1B in sales

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic CFO Ellis: Covidien deal frees up 25% more cash

February 17, 2015 by Brad Perriello

Medtronic CFO Gary Ellis tells analysts that the $50 billion acquisition of Covidien pushes its available free cash flow from 35% to 60%, or about $7 billion annually.

Medtronic CFO Ellis: Covidien deal frees up 25% more cash

FLASH: Medtronic's profits jump 30% in Street-beating Q3

February 17, 2015 by Brad Perriello

Medtronic says its fiscal 3rd-quarter profits jumped nearly 30% as it tops Wall Street's forecast, without any contribution from Covidien.

FLASH: Medtronic's Q3 earnings soar 30%

MDT's Ev3 pays $1.3m in whistleblower suit | Medtech legal news for the week of February 16, 2015

February 16, 2015 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Medtronic's new Ev3 unit pays $1.3m in whistleblower suit; Medtronic settles another whistleblower suit for $2.8m; Ex-NFL great Gault must face SEC fraud charges; Appeals court upholds Abiomed win in shareholders lawsuit; Pelvic mesh lawsuits: Boston Scientific wants 700 Philly cases sent to federal court

Medtronic's new Ev3 unit pays $1.3m in whistleblower suit

February 6, 2015 by Brad Perriello

Studies: After stroke, clot removal saves brain function

February 11, 2015 by MassDevice

Studies of thrombectomy devices made by Medtronic's Covidien, Stryker and Penumbra show that they dramatically improve the likelihood that patients will recover from stroke.

Studies: After stroke, clot removal saves brain function

(Reuters) - Grabbing and removing a clot blocking blood flow to the brain via thrombectomy, rather than just administering clot-busting drugs, dramatically improves the likelihood that patients will recover from a stroke, according to 2 highly-anticipated studies released today.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

MDT's Ev3 pays $1.3m in whistleblower suit | The week in medtech M&A

February 11, 2015 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Medtronic's new Ev3 unit pays $1.3m in whistleblower suit; GPOs: Premier buys the rest of direct sourcer S2S Global; CareFusion crushes it in final quarter; BD beats Q1 estimates, raises outlook, shares jump; Zimmer revises Biomet bid for EU regulators

Medtronic's new Ev3 unit pays $1.3m in whistleblower suit

February 6, 2015 by Brad Perriello